Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
- 1 July 1998
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 352 (9123), 179-184
- https://doi.org/10.1016/s0140-6736(98)03228-0
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Cancer risk of hypertensive patients taking calcium antagonistsJournal of Hypertension, 1998
- Use of calcium channel blockers and breast carcinoma risk in postmenopausal womenCancer, 1997
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Cancer Risk in Users of Calcium Channel BlockersHypertension, 1997
- Calcium-channel blockers and risk of cancerThe Lancet, 1997
- Calcium-channel blockade and incidence of cancer in aged populationsThe Lancet, 1996
- Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.JCI Insight, 1996
- Do Calcium Channel Blockers Increase the Risk of Cancer?American Journal of Hypertension, 1996
- The Role of Angiotensin II and Prostaglandins in Arcade Formation in a Developing Microvascular NetworkJournal of Vascular Research, 1996
- Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture.Hypertension, 1979